Lantheus announced that the U.S. Food and Drug Administration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
News | FDA
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Home March 06, 2024
Home
Konica Minolta's Exa Platform
Feature | PACS | By Melinda Taschetta-Millane
The Emergence of Cloud-based PACS, and Other Trends

Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital ...

Home March 06, 2024
Home
Hal Wolf, president and CEO of HIMSS
Feature
One on One ... with Hal Wolf, FHIMSS

Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems ...

Home March 06, 2024
Home
Videos | HIMSS
VIDEO: One on One with Hal Wolf, FHIMSS, HIMSS President and CEO

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Home March 05, 2024
Home
A look at DAIC's top-viewed content for February 2024
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
A Look at February's Top 10

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 05, 2024
Home
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision
Sponsored Content | Feature | Cardiac Imaging
SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

Home March 05, 2024
Home
NIH-funded observational study shows risk grows sharply with more frequent use
News | Stroke
Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

Home March 05, 2024
Home
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow
News | Stroke
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
Home
FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring.
News | Heart Failure
FIRE1 Completes Enrollment in US Early Feasibility Study of Innovative Remote Heart Failure Monitoring System

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
During the upcoming Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends.
News | HIMSS
Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

March 6, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and Exhibition ...

Home March 05, 2024
Home
First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence
News | Drug-Eluting Balloons
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon

March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA) ...

Home March 01, 2024
Home
Maternal stress may lead to adverse changes in mental, physical health that impact development of the fetal heart
News | Pediatric Cardiology
Severe Maternal Grief Associated with Increased Risk of Heart Failure in Child

March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a ...

Home March 01, 2024
Home
Sumeet Chugh, MD. Photo by Cedars-Sinai
News | Artificial Intelligence
New Studies: AI Captures Electrocardiogram Patterns That Could Signal a Future Sudden Cardiac Arrest

March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...

Home March 01, 2024
Home
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
News | ACC
American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

Home February 29, 2024
Home
On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI."
News | Cardiac Imaging
Webinar on Optimizing Structural Heart Workflows to be Rescheduled

PLEASE NOTE: This webinar has been postponed to a later date. A new date will be posted in the coming days. On March 25 ...

Home February 29, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now